Eagle Harbor Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Eagle Harbor Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Sell	24,852 -523	-2%	-$30K	1.12%	21
2026 Q1	$1.54M	Buy	25,375 +4	+0%	+$233	1.32%	16
2025 Q4	$1.37M	Sell	25,371 -751	-3%	-$36.1K	1.13%	23
2025 Q3	$1.18M	Sell	26,122 -280	-1%	-$13.1K	1.02%	25
2025 Q2	$1.22M	Sell	26,402 -2,010	-7%	-$98.7K	1.18%	20
2025 Q1	$1.73M	Sell	28,412 -30	-0.1%	-$1.75K	1.76%	12
2024 Q4	$1.61M	Sell	28,442 -1,484	-5%	-$82.9K	1.61%	13
2024 Q3	$1.55M	Sell	29,926 -3,175	-10%	-$149K	1.54%	13
2024 Q2	$1.37M	Buy	33,101 +6,532	+25%	+$292K	1.47%	15
2024 Q1	$1.44M	Sell	26,569 -1,850	-7%	-$94.2K	1.53%	15
2023 Q4	$1.46M	Buy	28,419 +5,422	+24%	+$285K	1.68%	14
2023 Q3	$1.33M	Buy	22,997 +1,484	+7%	+$90.9K	1.75%	16
2023 Q2	$1.38M	Buy	21,513 +952	+5%	+$63.8K	1.8%	15
2023 Q1	$1.43M	Buy	20,561 +524	+3%	+$37K	1.93%	11
2022 Q4	$1.44M	Sell	20,037 -394	-2%	-$29.7K	2.11%	9
2022 Q3	$1.45M	Buy	20,431 +585	+3%	+$42.4K	2.5%	7
2022 Q2	$1.53M	Buy	19,846 +495	+3%	+$37.7K	2.36%	7
2022 Q1	$1.41M	Sell	19,351 -715	-4%	-$48K	1.83%	12
2021 Q4	$1.25M	Buy	+20,066	New	+$1.18M	1.65%	10

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Eagle Harbor Asset Management's BMY Position: Q2 2026 in Review

Eagle Harbor Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, selling an estimated $30K and leaving 24,852 shares worth $1.43M. The position accounts for 1.12% of the portfolio, ranked #21.

Eagle Harbor Asset Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.73M in Q1 2025. 2,497 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Eagle Harbor Asset Management held 24,852 shares of Bristol-Myers Squibb worth $1.43M as of Q2 2026.
Eagle Harbor Asset Management sold 523 Bristol-Myers Squibb shares in Q2 2026, an estimated $30K.
Bristol-Myers Squibb made up 1.12% of Eagle Harbor Asset Management's portfolio in Q2 2026, its #21 holding.
Eagle Harbor Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
Eagle Harbor Asset Management's Bristol-Myers Squibb position peaked at $1.73M in Q1 2025.
2,497 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Eagle Harbor Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.